Back
Translating new therapeutic opportunities
TARGETING CDK7 IN ER+ BREAST CANCER
Simak Ali
ANDROGEN RECEPTOR AGONISTS FOR AR+ DISEASE
Carlo Palmieri
RATIONALE AND PROGRESS IN TARGETING FOXA1
Jason Carroll
CHAIRS: Rob Clarke & Adrian Harris